{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:45:08Z","timestamp":1761101108108},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":9503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1093\/annonc\/5.suppl_2.s143","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:54:55Z","timestamp":1353362095000},"page":"S143-S146","source":"Crossref","is-referenced-by-count":81,"special_numbering":"S2","title":["Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma"],"prefix":"10.1016","volume":"5","author":[{"given":"A.Z.S.","family":"Rohatiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Lister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hon.2900020306","article-title":"Clinical and prognostic relevance of the Kiel classification of non-Hodgkin\u2019s lymphomas: Results of a prospective multicentre study by the Kiel lymphoma study group","volume":"2","author":"Brittinger","year":"1984","journal-title":"Haematol Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0010","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","article-title":"Follicular lymphoma; Prognostic factors for response and survival","volume":"4","author":"Gallagher","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood.V47.5.747.747","article-title":"Treatment of advanced non-Hodgkin\u2019s lymphomas with favourable histology: Preliminary results of a prospective trial","volume":"47","author":"Portlock","year":"1976","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0020","first-page":"23","volume":"41","author":"Kennedy","year":"1978","journal-title":"Combination versus successive single-agent chemotherapy in lymphocytic lymphoma Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0609.1989.tb01205.x","article-title":"Follicular low-grade non-Hodgkin\u2019s lymphoma: Long-term outcome with or without tumour progression","volume":"42","author":"Ersboll","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0030","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/1097-0142(19821215)50:12<2708::AID-CNCR2820501203>3.0.CO;2-G","article-title":"Malignant lymphoma II: Prognostic factors and reponse to treatment of 473 patients at the National Cancer Institute","volume":"50","author":"Anderson","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0035","first-page":"92","article-title":"Management of indolent non-Hodgkin\u2019s lymphomas","volume":"7","author":"Portlock","year":"1980","journal-title":"Sem Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","article-title":"Histological transformation of non-Hodgkin\u2019s lymphoma: A prospective study","volume":"44","author":"Cullen","year":"1979","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1097-0142(197908)44:2<529::AID-CNCR2820440222>3.0.CO;2-Y","article-title":"Non-Hodgkin\u2019s lymphoma: A study of the evolution of the disease based upon 92 autopsied cases","volume":"44","author":"Risdall","year":"1979","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M","article-title":"An autopsy study of histologic progression in non-Hodgkin\u2019s lymphoma: 192 cases from the National Cancer Institute","volume":"52","author":"Garvin","year":"1983","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.1.6112.533","article-title":"Comparison of combined and single agent chemotherapy in non-Hodgkin\u2019s lymphoma of favourable histological subtype","volume":"1","author":"Lister","year":"1978","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1200\/JCO.1985.3.6.769","article-title":"Moderate versus aggressive chemotherapy of nodular poorly differentiated lymphoma","volume":"3","author":"Ezdinli","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0065","first-page":"599","volume":"60","author":"Philip","year":"1985","journal-title":"Massive chemotherapy with ABMT in 50 cases of bad prognosis non-Hodgkin\u2019s lymphoma Br J Haematol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0070","first-page":"1493","volume":"316","author":"Philip","year":"1987","journal-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0075","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198706113162402","article-title":"Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma with a poor prognosis","volume":"316","author":"Takvorian","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0080","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198406143102403","article-title":"Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow","volume":"310","author":"Phillips","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0085","series-title":"Bone Marrow Transplant","article-title":"High-dose therapy (HDT) and autologous BMT (ABMT) in advanced poor-prognosis non-Hodgkin\u2019s lymphoma (NH","author":"Santini","year":"1987"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0090","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1200\/JCO.1988.6.8.1303","article-title":"Autologous bone marrow transplantation for patients with poor prognosis lymphoma","volume":"6","author":"Gulati","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0095","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1200\/JCO.1989.7.11.1621","article-title":"Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin\u2019s lymphomas who are still responsive to conventional-dose therapy","volume":"7","author":"Gribben","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.1990.8.4.638","article-title":"Autologous transplantation for malignant lymphoma; A report of 101 cases from Seattle","volume":"8","author":"Petersen","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(84)92907-6","article-title":"Anti-B1 monoclonal antibody and complement treatment in autologous bone marrow transplantation for relapsed B-cell non-Hodgkin\u2019s lymphoma","volume":"2","author":"Nadler","year":"1984","journal-title":"Lancet"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0110","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood.V74.7.2579.2579","article-title":"Autologous bone marrow transplantation in follicular non-Hodgkin\u2019s lymphoma before and after histologic transformation","volume":"74","author":"Schouten","year":"1989","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10428199209061555","article-title":"High-dose chemotherapy with autologous marrow transplantation in follicular lymphoma","volume":"7","author":"Colombat","year":"1992","journal-title":"Leukemia and Lymphoma"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0609.1991.tb01539.x","article-title":"Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin\u2019s lymphoma","volume":"46","author":"Fouillard","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1093\/annonc\/5.suppl_2.S143_bb0125","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1182\/blood.V77.11.2524.2524","article-title":"Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin\u2019s lymphoma","volume":"77","author":"Freedman","year":"1991","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/5\/suppl_2\/S143\/6679418\/5-suppl_2-S143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:16:10Z","timestamp":1589537770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419633922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":25,"alternative-id":["S0923753419633922"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/5.suppl_2.s143","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1994]]}}}